Header Logo

Connection

Ian Dunn to Meningioma

Back to Details
This is a "connection" page, showing publications Ian Dunn has written about Meningioma.
Ian Dunn
Connection Strength
9.891
Meningioma
  1. WHO grade 3 pediatric meningioma: a systematic review of clinical features and patient-level analysis of prognostic factors. Childs Nerv Syst. 2026 Jul 14; 42(1).
    View in: PubMed
    Score: 0.913
  2. Open Surgical Approaches for Meningiomas. Neurosurg Clin N Am. 2023 Jul; 34(3):381-391.
    View in: PubMed
    Score: 0.728
  3. Medical management of meningioma in the era of precision medicine. Neurosurg Focus. 2018 04; 44(4):E3.
    View in: PubMed
    Score: 0.514
  4. High-grade meningiomas: biology and implications. Neurosurg Focus. 2018 04; 44(4):E2.
    View in: PubMed
    Score: 0.514
  5. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017 09 18; 15(1):34.
    View in: PubMed
    Score: 0.496
  6. Current and emerging principles in surgery for meningioma. Chin Clin Oncol. 2017 Jul; 6(Suppl 1):S7.
    View in: PubMed
    Score: 0.488
  7. Genomic profile of human meningioma cell lines. PLoS One. 2017; 12(5):e0178322.
    View in: PubMed
    Score: 0.485
  8. Checkpoint inhibition in meningiomas. Immunotherapy. 2016 06; 8(6):721-31.
    View in: PubMed
    Score: 0.453
  9. Genomic and Epigenomic Landscape in Meningioma. Neurosurg Clin N Am. 2016 Apr; 27(2):167-79.
    View in: PubMed
    Score: 0.448
  10. Genomic landscape of intracranial meningiomas. J Neurosurg. 2016 09; 125(3):525-35.
    View in: PubMed
    Score: 0.441
  11. Above and below: anterior fossa meningioma resection. World Neurosurg. 2015 May; 83(5):771-2.
    View in: PubMed
    Score: 0.395
  12. Preclinical Models of Meningioma. Adv Exp Med Biol. 2023; 1416:199-211.
    View in: PubMed
    Score: 0.179
  13. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 01 20; 41(3):618-628.
    View in: PubMed
    Score: 0.176
  14. A molecularly integrated grade for meningioma. Neuro Oncol. 2022 05 04; 24(5):796-808.
    View in: PubMed
    Score: 0.171
  15. Posterior Clinoid Meningioma-A Formidable Entity: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2022 05 01; 22(5):e216.
    View in: PubMed
    Score: 0.171
  16. Biology and Treatment of Meningiomas: A Reappraisal. Hematol Oncol Clin North Am. 2022 02; 36(1):133-146.
    View in: PubMed
    Score: 0.168
  17. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 01 05; 24(1):101-113.
    View in: PubMed
    Score: 0.167
  18. Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status. J Neurooncol. 2021 Feb; 151(3):443-449.
    View in: PubMed
    Score: 0.157
  19. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection. Neurosurgery. 2020 10 15; 87(5):900-909.
    View in: PubMed
    Score: 0.153
  20. Impact of insurance on hospital course and readmission after resection of benign meningioma. J Neurooncol. 2020 Aug; 149(1):131-140.
    View in: PubMed
    Score: 0.151
  21. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020 Jan; 146(1):111-120.
    View in: PubMed
    Score: 0.144
  22. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
    View in: PubMed
    Score: 0.143
  23. Advances in multidisciplinary therapy for meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i18-i31.
    View in: PubMed
    Score: 0.136
  24. Molecular and translational advances in meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i4-i17.
    View in: PubMed
    Score: 0.136
  25. Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i44-i61.
    View in: PubMed
    Score: 0.136
  26. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. Neuro Oncol. 2019 01 01; 21(1):26-36.
    View in: PubMed
    Score: 0.135
  27. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 2019 01; 8(1):13-20.
    View in: PubMed
    Score: 0.135
  28. Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One. 2017; 12(11):e0187908.
    View in: PubMed
    Score: 0.125
  29. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol. 2017 04 01; 19(4):535-545.
    View in: PubMed
    Score: 0.120
  30. Hybrid Surgery Management of Giant Hypervascular Tumors: Intraoperative Endovascular Embolization with Microsurgical Resection. World Neurosurg. 2017 Jun; 102:157-166.
    View in: PubMed
    Score: 0.119
  31. Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis. J Neurooncol. 2017 01; 131(1):59-67.
    View in: PubMed
    Score: 0.117
  32. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016 05; 18(5):649-55.
    View in: PubMed
    Score: 0.111
  33. A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro Oncol. 2016 Feb; 18(2):269-74.
    View in: PubMed
    Score: 0.107
  34. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015 Dec 15; 121(24):4376-81.
    View in: PubMed
    Score: 0.107
  35. ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015 Jun; 208(6):345-50.
    View in: PubMed
    Score: 0.104
  36. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015 Mar 10; 6(7):4704-16.
    View in: PubMed
    Score: 0.104
  37. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 2014 Nov 15; 5(21):10596-606.
    View in: PubMed
    Score: 0.102
  38. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014 Nov; 16(11):1547-53.
    View in: PubMed
    Score: 0.099
  39. True petroclival meningiomas: results of surgical management. J Neurosurg. 2014 Jan; 120(1):40-51.
    View in: PubMed
    Score: 0.095
  40. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013 Mar; 45(3):285-9.
    View in: PubMed
    Score: 0.090
  41. Meningiomas involving the optic canal: pattern of involvement and implications for surgical technique. Neurosurg Focus. 2011 May; 30(5):E12.
    View in: PubMed
    Score: 0.080
  42. Delayed Carotid Pseudoaneurysms from Iatrogenic Clival Meningeal Branches Avulsion: Recognition and Proposed Management. World Neurosurg. 2017 Aug; 104:736-744.
    View in: PubMed
    Score: 0.030
  43. High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol. 2016 Jul; 33(3):222-7.
    View in: PubMed
    Score: 0.028
  44. Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci U S A. 2013 Jan 29; 110(5):1611-6.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.